This week in #ScienceNews and #Innovation, Moderna and the Pfizer/BioNTech collaboration race to the market with their Covid-19 vaccines. With Moderna announcing an efficacy of 94.1% and Pfizer/BioNTech reporting a 95% efficacy, both companies are aiming to release 70 million combined doses by the end of the year.
And with the ongoing pandemic in mind, many of us may be facing insomnia and sleep disorders. Researchers from Nagoya University discuss how stress affects our sleep quality and our circadian clock.
Lastly, if you are looking for a unique Black Friday R&D deal, look no further! Astellas Pharma is offering up research projects for acquisition, including ongoing therapeutics for inflammatory and kidney diseases.
(Image Credit: Astellas)